AF5078SP

Human/Mouse/Rat RelA/NF kappa B p65 Antibody, R&D Systems™

Manufacturer: R&D Systems

Select a Size

Pack Size SKU Availability Price
Each of 1 AF5078SP-Each-of-1 In Stock ₹ 19,464.90

AF5078SP - Each of 1

₹ 19,464.90

In Stock

Quantity

1

Base Price: ₹ 19,464.90

GST (18%): ₹ 3,503.682

Total Price: ₹ 22,968.582

Antigen

RelA/NFkB p65

Classification

Polyclonal

Conjugate

Unconjugated

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Gene Alias

MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65

Host Species

Sheep

Purification Method

Affinity Purified

Regulatory Status

RUO

Gene ID (Entrez)

5970

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications

ChIP Assay, Immunocytochemistry, Immunohistochemistry

Concentration

LYOPH

Dilution

Western Blot 1 μg/mL, Simple Western 20 μg/mL, Immunohistochemistry 5-15 μg/mL, Chromatin Immunoprecipitation (ChIP) 5 μg/5 x 10^6 cells, Immunocytochemistry 5-15 μg/mL, Knockout Validated 1 μg/mL

Gene Accession No.

Q04206

Gene Symbols

RELA

Immunogen

E. coli-derived recombinant human RelA/NF kappa B p65 isoform 1 Asn456-Ser551 Accession # Q04206

Quantity

25 μg

Primary or Secondary

Primary

Test Specificity

Detects human and mouse RelA/NF kappa B p65 in Western blots.

Target Species

Human, Mouse

Isotype

IgG

Description

  • RelA/NFkB p65 Polyclonal specifically detects RelA/NFkB p65 in Human, Mouse, Rat samples
  • It is validated for Western Blot, Simple Western, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP), Immunocytochemistry, Knockout Validated.

Compare Similar Items

Show Difference

Img

R&D Systems

AF5078SP

--


Antigen:
RelA/NFkB p65

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Gene Alias:
MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65

Host Species:
Sheep

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Gene ID (Entrez):
5970

Reconstitution:
Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications:
ChIP Assay, Immunocytochemistry, Immunohistochemistry

Concentration:
LYOPH

Dilution:
Western Blot 1 μg/mL, Simple Western 20 μg/mL, Immunohistochemistry 5-15 μg/mL, Chromatin Immunoprecipitation (ChIP) 5 μg/5 x 10^6 cells, Immunocytochemistry 5-15 μg/mL, Knockout Validated 1 μg/mL

Gene Accession No.:
Q04206

Gene Symbols:
RELA

Immunogen:
E. coli-derived recombinant human RelA/NF kappa B p65 isoform 1 Asn456-Ser551 Accession # Q04206

Quantity:
25 μg

Primary or Secondary:
Primary

Test Specificity:
Detects human and mouse RelA/NF kappa B p65 in Western blots.

Target Species:
Human, Mouse

Isotype:
IgG

Img

A2B Chem

AF50793

--


Antigen:
__

Classification:
__

Conjugate:
__

Formulation:
__

Gene Alias:
__

Host Species:
__

Purification Method:
__

Regulatory Status:
__

Gene ID (Entrez):
__

Reconstitution:
__

Content And Storage:
__

Applications:
__

Concentration:
__

Dilution:
__

Gene Accession No.:
__

Gene Symbols:
__

Immunogen:
__

Quantity:
__

Primary or Secondary:
__

Test Specificity:
__

Target Species:
__

Isotype:
__

Img

R&D Systems

AF507SP

--


Antigen:
BMP-6

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Gene Alias:
BMP6, BMP-6, bone morphogenetic protein 6, vegetal related growth factor (TGFB-related), vegetal-related (TGFB related) cytokine, VG-1-R, VG-1-related protein, Vg1-related sequence, VGR, Vgr-1, VGR1

Host Species:
Goat

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Gene ID (Entrez):
654

Reconstitution:
Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications:
Western Blot, Immunohistochemistry, Neutralization

Concentration:
LYOPH

Dilution:
Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Neutralization 0.75-3.75 ug/mL

Gene Accession No.:
P22004

Gene Symbols:
BMP6

Immunogen:
E. coli-derived recombinant human BMP-6 Gln382-His513 Accession # P22004

Quantity:
25 μg

Primary or Secondary:
Primary

Test Specificity:
Detects human BMP-6 in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross-reactivity with recombinant human (rh) BMP-7 is observed and less than 1% cross-reactivity with rhBMP-2, rhBMP-4, rhBMP-5mature, rhBMP-8A, and recombinant mouse BMP-6 is observed.

Target Species:
Human

Isotype:
IgG

Img

R&D Systems

AF508

--


Antigen:
CCL23/Ck beta 8-1/MIP3

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
__

Gene Alias:
C6 beta-chemokine, chemokine (C-C motif) ligand 23, Ck beta 8-1, CKb8, CKB-8, Ckb81, CK-beta-8, hmrp-2a, Macrophage inflammatory protein 3, MIP3, MIP-3CK-BETA-8, MPIF1, MPIF-1Ckb-8-1, Myeloid progenitor inhibitory factor 1, SCYA23C-C motif chemokine 23, small inducible cytokine subfamily A (Cys-Cys), member 23, Small-inducible cytokine A23

Host Species:
Goat

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Gene ID (Entrez):
6368

Reconstitution:
Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications:
Western Blot, Neutralization

Concentration:
LYOPH

Dilution:
Western Blot 0.1 ug/mL, Neutralization 0.15-0.75 ug/mL

Gene Accession No.:
AAD10846

Gene Symbols:
CCL23

Immunogen:
E. coli-derived recombinant human CCL23/Ck beta 8-1 Met46-Asn137 Accession # AAD10846

Quantity:
100 μg

Primary or Secondary:
Primary

Test Specificity:
Detects CCL23/Ck beta 8-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 20% cross-reactivity with recombinant human MPIF-1 is observed. Additionally, in direct ELISAs, no cross-reactivity with _______ is observed. Neutralizes the biological activity of human CCL23/Ck beta 8-1. It will also neutralize the biological activity of recombinant human MPIF-1 at a 10-fold higher Ig concentration.

Target Species:
Human

Isotype:
IgG